Benefit of switching the Protease Inhibitor (PI) by nevirapine in PI - experienced patients suffering acquired HIV-related lipodystrophy syndrome (AHL). Interim analysis at 6 months of follw-up
L. Ruiz et al., Benefit of switching the Protease Inhibitor (PI) by nevirapine in PI - experienced patients suffering acquired HIV-related lipodystrophy syndrome (AHL). Interim analysis at 6 months of follw-up, SEVENTH EUROPEAN CONFERENCE ON CLINICAL ASPECTS AND TREATMENT OF HIV-INFECTION, 1999, pp. 49-54